← Eichor
Study identifier: NCT05368987 Synced from ClinicalTrials.gov · July 30, 2026
● Recruiting

Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans

Condition: PTSD  ·  Sponsor: The University of Texas Health Science Center, Houston

PhaseNA
Planned participants250
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersYes

About this study

This study aims to explore the mechanisms of how transcranial magnetic stimulation (TMS) impacts fear circuits. The overarching objectives are to understand how varying TMS parameters affect targeted brain regions in order to optimize its impact on enhancing fear extinction memory consolidation in a population with known fear extinction deficiencies: post-traumatic stress disorder (PTSD). 250 subjects will take part in this research study across UTHealth Houston. The study will include preliminary screenings, baseline visits, and experimental visits across four days

This description comes directly from the study's public registry record.

Talk to the study team

Mohammed Milad, PhD  ·  713-486-2754  ·  Mohammed.R.Milad@uth.tmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UTHealth HoustonHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05368987